Insider Trading activities of Array Biopharma Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Array Biopharma Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Array Biopharma Inc since year 2005. Table 2 shows the detailed insider transactions of Array Biopharma Inc since 2005. The reporting company's ticker symbol is ARRY. The reporting company's CIK number is 1100412.
The total value of stock buying since 2005 is $24,123,640.
The total value of stock sales since 2005 is $46,019,336.
The total value of stock option exercises since 2005 is $5,434,954.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Array Biopharma Inc (ARRY).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 0 $0 25,000 $261,750
2017-09 0 $0 78,793 $971,938 90,000 $952,200
2017-08 0 $0 0 $0 20,000 $75,400
2017-04 0 $0 0 $0 50,154 $0
2017-03 0 $0 70,000 $633,150 70,000 $277,875
2016-10 0 $0 0 $0 25,000 $145,750
2016-09 400,000 $1,403,720 2,892,578 $17,253,088 95,890 $353,834
2016-01 1,300,000 $4,621,500 0 $0 0 $0
2015-10 100,140 $450,630 0 $0 0 $0
2015-09 682,452 $3,132,050 0 $0 95,891 $496,715
2015-08 2,421,393 $13,736,806 0 $0 0 $0
2015-05 0 $0 25,000 $184,475 25,000 $96,500
2015-03 0 $0 131,576 $1,068,072 243,202 $1,572,584
2013-11 0 $0 11,866 $68,704 0 $0
2013-09 0 $0 3,376,186 $20,260,308 0 $0
2013-08 0 $0 75,384 $529,086 70,625 $210,067
2013-07 0 $0 5,000 $32,500 68,723 $252,659
2013-04 0 $0 0 $0 20,000 $54,800
2012-10 0 $0 28,547 $162,318 0 $0
2012-02 0 $0 1,545 $4,094 0 $0
2012-01 0 $0 1,994 $4,107 0 $0
2011-12 119,600 $246,468 1,743 $4,096 0 $0
2011-11 64,253 $142,063 1,656 $4,090 0 $0
2011-10 0 $0 1,977 $4,112 0 $0
2011-09 0 $0 2,034 $4,108 0 $0
2011-08 5,000 $11,100 4,110 $9,012 0 $0
2011-07 0 $0 1,638 $4,095 0 $0
2011-06 25,000 $54,250 1,720 $4,093 0 $0
2011-05 20,000 $57,200 1,484 $4,081 0 $0
2011-04 0 $0 1,696 $5,247 0 $0
2011-03 0 $0 1,310 $4,074 0 $0
2011-02 0 $0 1,403 $4,082 0 $0
2011-01 0 $0 28,270 $91,959 0 $0
2010-12 0 $0 1,256 $4,069 0 $0
2010-11 0 $0 11,220 $36,792 0 $0
2010-10 0 $0 21,292 $70,087 0 $0
2010-09 0 $0 1,415 $4,075 0 $0
2010-08 0 $0 6,336 $20,583 0 $0
2010-07 0 $0 1,309 $4,070 0 $0
2010-06 0 $0 2,858 $9,218 33,789 $20,273
2010-05 4,000 $14,840 1,183 $4,069 0 $0
2010-04 0 $0 1,074 $4,059 0 $0
2010-03 0 $0 1,661 $4,086 0 $0
2010-02 0 $0 7,993 $19,433 0 $0
2010-01 0 $0 7,325 $19,374 10,000 $6,000
2009-12 0 $0 1,533 $4,077 0 $0
2009-11 0 $0 2,045 $4,110 28,863 $17,317
2009-10 0 $0 2,049 $4,108 228,751 $137,250
2009-09 0 $0 1,315 $3,642 0 $0
2009-08 0 $0 882 $3,677 0 $0
2009-07 0 $0 925 $3,653 0 $0
2009-06 0 $0 1,170 $3,580 0 $0
2009-05 0 $0 1,170 $3,657 0 $0
2008-12 0 $0 0 $0 33,883 $7,962
2008-11 3,000 $9,825 0 $0 0 $0
2008-04 0 $0 0 $0 71,249 $42,749
2008-03 37,500 $233,365 0 $0 0 $0
2008-02 0 $0 0 $0 57,284 $21,551
2008-01 0 $0 0 $0 20,694 $4,863
2007-12 0 $0 0 $0 10,000 $6,000
2007-11 0 $0 0 $0 10,000 $6,000
2007-09 0 $0 10,000 $130,000 0 $0
2007-08 0 $0 12,000 $137,652 14,000 $116,480
2007-02 0 $0 20,000 $281,100 20,000 $4,700
2007-01 0 $0 26,900 $376,600 0 $0
2006-12 0 $0 0 $0 8,500 $1,997
2006-11 0 $0 253,133 $2,869,786 249,858 $291,678
2006-10 0 $0 5,000 $49,750 0 $0
2006-03 0 $0 5,000 $47,450 0 $0
2006-02 0 $0 54,365 $489,440 0 $0
2005-06 0 $0 15,000 $92,250 0 $0
2005-03 1,315 $9,823 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Array Biopharma Inc insiders (ARRY)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-27 Baum Charles M Option Ex 5,000 10.47 52,350
2017-10-27 Fyfe Gwen A. Option Ex 5,000 10.47 52,350
2017-10-27 Orwin John A Option Ex 5,000 10.47 52,350
2017-10-27 Van Lunsen Gil J Option Ex 5,000 10.47 52,350
2017-10-27 Lefkoff Kyle Option Ex 5,000 10.47 52,350
2017-09-29 Van Lunsen Gil J Sale 39,928 12.36 493,510
2017-09-29 Van Lunsen Gil J Option Ex 45,000 10.58 476,100
2017-09-29 Lefkoff Kyle Sale 38,865 12.31 478,428
2017-09-29 Lefkoff Kyle Option Ex 45,000 10.58 476,100
2017-08-14 Haddock Jason (CFO) Option Ex 20,000 3.77 75,400
2017-04-01 Sandor Victor (Chief Medical Officer) Option Ex 7,812 .00 0
2017-04-01 Saccomano Nicholas A (CSO) Option Ex 6,875 .00 0
2017-04-01 Robbins Andrew R (COO) Option Ex 9,843 .00 0
2017-04-01 Squarer Ron (CEO) Option Ex 18,906 .00 0
2017-04-01 Moore John R (VP, General Counsel) Option Ex 6,718 .00 0
2017-03-31 Lefkoff Kyle Sale 45,000 8.92 401,400
2017-03-31 Lefkoff Kyle Option Ex 45,000 4.03 181,125
2017-03-28 Baum Charles M Sale 25,000 9.27 231,750
2017-03-28 Baum Charles M Option Ex 25,000 3.87 96,750
2016-10-29 Baum Charles M Option Ex 5,000 5.83 29,150
2016-10-29 Fyfe Gwen A. Option Ex 5,000 5.83 29,150
2016-10-29 Orwin John A Option Ex 5,000 5.83 29,150
2016-10-29 Van Lunsen Gil J Option Ex 5,000 5.83 29,150
2016-10-29 Lefkoff Kyle Option Ex 5,000 5.83 29,150
2016-09-28 Green Jeremy Sale 2,492,578 6.36 15,852,796
2016-09-22 Sandor Victor (Chief Medical Officer) Option Ex 95,890 3.69 353,834
2016-09-15 Green Jeremy Buy 28,000 3.50 98,000
2016-09-15 Green Jeremy Sale 7,300 3.54 25,842
2016-09-14 Green Jeremy Buy 372,000 3.51 1,305,720
2016-09-14 Green Jeremy Sale 392,700 3.50 1,374,450
2016-01-20 Green Jeremy Buy 300,000 3.19 957,000
2016-01-12 Green Jeremy Buy 75,000 3.60 270,000
2016-01-11 Green Jeremy Buy 275,000 3.54 973,500
2016-01-08 Green Jeremy Buy 350,000 3.72 1,302,000
2016-01-07 Green Jeremy Buy 300,000 3.73 1,119,000
2015-10-01 Green Jeremy Buy 100,140 4.50 450,630
2015-09-30 Green Jeremy Buy 182,452 4.67 852,050
2015-09-29 Green Jeremy Buy 500,000 4.56 2,280,000
2015-09-22 Sandor Victor (Chief Medical Officer) Option Ex 95,891 5.18 496,715
2015-08-26 Green Jeremy Buy 49,900 5.48 273,452
2015-08-25 Green Jeremy Buy 220,000 5.45 1,199,000
2015-08-24 Green Jeremy Buy 410,000 5.32 2,181,200
2015-08-21 Green Jeremy Buy 160,000 5.45 872,000
2015-08-12 Green Jeremy Buy 205,000 5.93 1,215,650
2015-08-11 Green Jeremy Buy 327,500 5.85 1,915,875
2015-08-10 Green Jeremy Buy 180,000 5.81 1,045,799
2015-08-07 Green Jeremy Buy 276,543 5.67 1,567,998
2015-08-06 Green Jeremy Buy 592,450 5.85 3,465,832
2015-05-08 Baum Charles M (Director) Sale 25,000 7.38 184,475
2015-05-08 Baum Charles M (Director) Option Ex 25,000 3.86 96,500
2015-03-03 Lefkoff Kyle (Director) Sale 70,000 8.00 560,070
2015-03-03 Lefkoff Kyle (Director) Option Ex 70,000 2.77 193,900
2015-03-02 Robbins Andrews R (SVP, Commercial Operations) Sale 21,576 8.25 178,002
2015-03-02 Squarer Ron (CEO) Sale 40,000 8.25 330,000
2015-03-01 Sandor Victor (Chief Medical Officer.) Option Ex 17,440 7.96 138,822
2015-03-01 Saccomano Nicholas A (CSO) Option Ex 11,453 7.96 91,165
2015-03-01 Robbins Andrews R (SVP, Commercial Operations) Option Ex 32,069 7.96 255,269
2015-03-01 Squarer Ron (CEO) Option Ex 77,881 7.96 619,932
2015-03-01 Moore John R (VP, General Counsel) Option Ex 22,906 7.96 182,331
2015-03-01 Snitman David (COO and VP, Business Devel.) Option Ex 11,453 7.96 91,165
2013-11-29 Moore John R (VP, General Counsel) Sale 11,666 5.79 67,546
2013-11-13 Moore John R (VP, General Counsel) Sale 200 5.79 1,158
2013-09-27 Ratcliffe Liam (Director) Sale 863,521 5.99 5,170,763
2013-09-26 Ratcliffe Liam (Director) Sale 262,207 6.02 1,579,010
2013-09-16 Ratcliffe Liam (Director) Sale 319,033 6.14 1,957,586
2013-09-13 Ratcliffe Liam (Director) Sale 546,660 6.01 3,287,613
2013-09-12 Ratcliffe Liam (Director) Sale 807,479 6.10 4,923,199
2013-09-06 Ratcliffe Liam (Director) Sale 139,572 5.68 793,187
2013-09-05 Ratcliffe Liam (Director) Sale 201,598 5.77 1,163,422
2013-09-04 Ratcliffe Liam (Director) Sale 236,116 5.87 1,385,528
2013-08-02 Moore John R (VP, General Counsel) Sale 43,884 7.03 308,460
2013-08-02 Moore John R (VP, General Counsel) Option Ex 43,884 3.04 133,187
2013-08-01 Moore John R (VP, General Counsel) Sale 31,500 7.00 220,626
2013-08-01 Moore John R (VP, General Counsel) Option Ex 26,741 2.88 76,880
2013-07-25 Moore John R (VP, General Counsel) Option Ex 4,759 3.75 17,846
2013-07-24 Koch Kevin (President, CSO) Option Ex 22,286 3.75 83,572
2013-07-24 Carruthers Michael (CFO) Option Ex 15,321 3.75 57,453
2013-07-24 Snitman David (COO and VP, Business Devel.) Option Ex 21,357 3.75 80,088
2013-07-23 Moore John R (VP, General Counsel) Sale 5,000 6.50 32,500
2013-07-23 Moore John R (VP, General Counsel) Option Ex 5,000 2.74 13,700
2013-04-23 Moore John R (VP, General Counsel) Option Ex 20,000 2.74 54,800
2012-10-08 Moore John R (VP, General Counsel) Sale 28,547 5.69 162,318
2012-02-10 Carruthers Michael (CFO) Sale 1,545 2.65 4,094
2012-01-12 Carruthers Michael (CFO) Sale 1,994 2.06 4,107
2011-12-12 Carruthers Michael (CFO) Sale 1,743 2.35 4,096
2011-12-05 Lampert Mark N (10% Owner) Buy 4,300 2.14 9,197
2011-12-02 Lampert Mark N (10% Owner) Buy 32,100 2.10 67,377
2011-12-01 Lampert Mark N (10% Owner) Buy 83,200 2.04 169,894
2011-11-23 Lampert Mark N (10% Owner) Buy 64,253 2.21 142,063
2011-11-11 Carruthers Michael (CFO) Sale 1,656 2.47 4,090
2011-10-12 Carruthers Michael (CFO) Sale 1,977 2.08 4,112
2011-09-12 Carruthers Michael (CFO) Sale 2,034 2.02 4,108
2011-08-16 Caruthers Marvin H (Director) Sale 2,300 2.14 4,922
2011-08-12 Carruthers Michael (CFO) Sale 1,810 2.26 4,090
2011-08-11 Lefkoff Kyle (Director) Buy 5,000 2.22 11,100
2011-07-12 Carruthers Michael (CFO) Sale 1,638 2.50 4,095
2011-06-17 Conway Robert (CEO) Buy 25,000 2.17 54,250
2011-06-10 Carruthers Michael (CFO) Sale 1,720 2.38 4,093
2011-05-13 Conway Robert (CEO) Buy 20,000 2.86 57,200
2011-05-12 Carruthers Michael (CFO) Sale 1,484 2.75 4,081
2011-04-12 Carruthers Michael (CFO) Sale 1,340 3.04 4,073
2011-04-05 Moore John R (VP, General Counsel) Sale 356 3.30 1,174
2011-03-11 Carruthers Michael (CFO) Sale 1,310 3.11 4,074
2011-02-11 Carruthers Michael (CFO) Sale 1,403 2.91 4,082
2011-01-12 Carruthers Michael (CFO) Sale 1,272 3.20 4,070
2011-01-11 Moore John R (VP, General Counsel) Sale 2,366 3.30 7,807
2011-01-10 Moore John R (VP, General Counsel) Sale 593 3.30 1,956
2011-01-06 Moore John R (VP, General Counsel) Sale 24,039 3.25 78,126
2010-12-10 Carruthers Michael (CFO) Sale 1,256 3.24 4,069
2010-11-18 Lefkoff Kyle (Director) Sale 2,000 3.17 6,340
2010-11-17 Lefkoff Kyle (Director) Sale 3,000 3.28 9,840
2010-11-16 Lefkoff Kyle (Director) Sale 5,000 3.31 16,550
2010-11-12 Carruthers Michael (CFO) Sale 1,220 3.33 4,062
2010-10-12 Carruthers Michael (CFO) Sale 1,225 3.32 4,067
2010-10-05 Moore John R (VP, General Counsel) Sale 20,067 3.29 66,020
2010-09-14 Carruthers Michael (CFO) Sale 1,415 2.88 4,075
2010-08-23 Carruthers Michael (CFO) Sale 17 2.79 47
2010-08-03 Moore John R (VP, General Counsel) Sale 3,479 3.25 11,306
2010-08-02 Moore John R (VP, General Counsel) Sale 2,840 3.25 9,230
2010-07-23 Carruthers Michael (CFO) Sale 1,309 3.11 4,070
2010-06-29 Snitman David (COO and VP, Business Devel.) Option Ex 33,789 .60 20,273
2010-06-23 Carruthers Michael (CFO) Sale 1,208 3.37 4,070
2010-06-08 Caruthers Marvin H (Director) Sale 1,650 3.12 5,148
2010-05-21 Carruthers Michael (CFO) Sale 1,183 3.44 4,069
2010-05-07 Lefkoff Kyle (Director) Buy 4,000 3.71 14,840
2010-04-23 Carruthers Michael (CFO) Sale 1,074 3.78 4,059
2010-03-23 Carruthers Michael (CFO) Sale 1,661 2.46 4,086
2010-02-23 Carruthers Michael (CFO) Sale 1,707 2.40 4,096
2010-02-05 Carruthers Michael (CFO) Sale 6,286 2.44 15,337
2010-01-22 Carruthers Michael (CFO) Sale 1,644 2.49 4,093
2010-01-14 Bullock Francis J (Director) Option Ex 10,000 .60 6,000
2010-01-06 Carruthers Michael (CFO) Sale 5,681 2.69 15,281
2009-12-23 Carruthers Michael (CFO) Sale 1,533 2.66 4,077
2009-11-23 Carruthers Michael (Chief Financial Officer) Sale 2,045 2.01 4,110
2009-11-12 Koch Kevin (President, CSO) Option Ex 28,863 .60 17,317
2009-10-23 Carruthers Michael (CFO) Sale 2,049 2.00 4,108
2009-10-08 Conway Robert (CEO) Option Ex 228,751 .60 137,250
2009-09-25 Carruthers Michael (CFO) Sale 1,315 2.77 3,642
2009-08-24 Carruthers Michael (CFO) Sale 882 4.17 3,677
2009-07-30 Carruthers Michael (CFO) Sale 925 3.95 3,653
2009-06-22 Carruthers Michael (CFO) Sale 1,170 3.06 3,580
2009-05-26 Carruthers Michael (CFO) Sale 1,170 3.13 3,657
2008-12-22 Snitman David (COO and VP, Business Devel.) Option Ex 33,883 .23 7,962
2008-11-13 Lefkoff Kyle (Director) Buy 3,000 3.27 9,825
2008-04-16 Conway Robert (CEO) Option Ex 51,249 .60 30,749
2008-04-09 Conway Robert (CEO) Option Ex 20,000 .60 12,000
2008-03-10 Lefkoff Kyle (Director) Buy 5,000 5.38 26,925
2008-03-06 Williams Douglas E (Director) Buy 2,500 6.16 15,400
2008-03-05 Zabriskie John L (Director) Buy 30,000 6.37 191,040
2008-02-26 Carruthers Michael (CFO) Option Ex 22,165 .60 13,299
2008-02-12 Koch Kevin (President, CSO) Option Ex 35,119 .23 8,252
2008-01-04 Carruthers Michael (CFO) Option Ex 20,694 .23 4,863
2007-12-21 Conway Robert (CEO) Option Ex 10,000 .60 6,000
2007-11-16 Conway Robert (CEO) Option Ex 10,000 .60 6,000
2007-09-19 Carruthers Michael (CFO) Sale 10,000 13.00 130,000
2007-08-09 Van Lunsen Gil J (Director) Sale 12,000 11.47 137,652
2007-08-09 Van Lunsen Gil J (Director) Option Ex 14,000 8.32 116,480
2007-02-15 Carruthers Michael (CFO) Option Ex 20,000 .23 4,700
2007-02-05 Koch Kevin (President & CSO) Sale 20,000 14.05 281,100
2007-01-19 Koch Kevin (President & CSO) Sale 26,900 14.00 376,600
2006-12-27 Snitman David (COO and VP, Bus Development) Option Ex 8,500 .23 1,997
2006-11-20 Moore John R (VP, General Counsel) Sale 27,263 13.04 355,509
2006-11-20 Moore John R (VP, General Counsel) Option Ex 24,858 6.30 156,679
2006-11-15 Conway Robert (CEO) Sale 38,277 12.50 478,462
2006-11-15 Conway Robert (CEO) Option Ex 63,277 .60 37,966
2006-11-14 Conway Robert (CEO) Sale 11,723 12.50 146,537
2006-11-14 Conway Robert (CEO) Option Ex 11,723 .60 7,033
2006-11-13 Carruthers Michael (CFO) Sale 3,054 11.98 36,586
2006-11-10 Carruthers Michael (CFO) Sale 11,816 11.98 141,555
2006-11-09 Lefkoff Kyle (Director) Sale 51,000 11.80 601,800
2006-11-08 Carruthers Michael (CFO) Sale 10,000 10.85 108,500
2006-11-03 Conway Robert (CEO) Sale 83,755 10.01 838,387
2006-11-03 Conway Robert (CEO) Option Ex 133,755 .60 80,253
2006-11-02 Conway Robert (CEO) Sale 16,245 10.00 162,450
2006-11-02 Conway Robert (CEO) Option Ex 16,245 .60 9,747
2006-10-27 Carruthers Michael (CFO) Sale 5,000 9.95 49,750
2006-03-07 Carruthers Michael (CFO) Sale 5,000 9.49 47,450
2006-02-21 Lefkoff Kyle (Director) Sale 11,000 9.08 99,902
2006-02-17 Moore John R (VP, General Counsel) Sale 4,456 9.38 41,797
2006-02-17 Koch Kevin (President & CSO) Sale 20,000 9.38 187,680
2006-02-17 Carruthers Michael (CFO) Sale 5,000 8.99 44,950
2006-02-15 Carruthers Michael (CFO) Sale 5,000 8.49 42,450
2006-02-13 Carruthers Michael (CFO) Sale 4,403 8.15 35,893
2006-02-10 Carruthers Michael (CFO) Sale 4,506 8.16 36,768
2005-06-21 Carruthers Michael (CHIEF FINANCIAL OFFI) Sale 10,000 6.15 61,500
2005-03-24 Van Lunsen Gil J (Director) Buy 1,315 7.47 9,823

Insider trading activities including stock purchases, stock sales, and option exercises of ARRY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Array Biopharma Inc (symbol ARRY, CIK number 1100412) see the Securities and Exchange Commission (SEC) website.